1. Louis, D. N. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol131, 803–820 (2016).
2. Aoki, K. et al. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro-Oncology20, 66–77 (2018).
3. The Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med372, 2481–2498 (2015).
4. Marra, J. S. et al. Survival after radiation therapy for high-grade glioma. Reports of Practical Oncology & Radiotherapy24, 35–40 (2019).
5. Patel, S., Wang, F.-H., Whiteside, T. L. & Kasid, U. Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: Implications in metastasis and/or radiation response. Oral Oncology33, 197–203 (1997).
6. Xing, Y. et al. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway. Cell Commun Signal16, 43 (2018).
7. Dong, Q. et al. TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma. Oncotarget8, 15689–15703 (2017).
8. Zhong, M. et al. TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer. Int. J. Biol. Sci.16, 272–283 (2020).
9. Xiao, M. et al. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma. Human Pathology62, 40–49 (2017).
10. Li, Y. et al. Expression of tumor necrosis factor α-induced protein 8 is upregulated in human gastric cancer and regulates cell proliferation, invasion and migration. Molecular Medicine Reports12, 2636–2642 (2015).
11. Zhang, C. et al. The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence: The Significance of TNFAIP8 in Prostate Cancer. Int. J. Cancer133, 31–42 (2013).
12. Zhong, M. et al. TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT. J. Cancer11, 3061–3071 (2020).
13. Guo, F. & Yuan, Y. Tumor Necrosis Factor Alpha-Induced Proteins in Malignant Tumors: Progress and Prospects. OTTVolume 13, 3303–3318 (2020).
14. Niture, S. et al. Oncogenic Role of Tumor Necrosis Factor α-Induced Protein 8 (TNFAIP8). Cells8, 9 (2018).
15. Ye, T. et al. TIPE1 impairs stemness maintenance in colorectal cancer through directly targeting β-catenin. Carcinogenesis bgz079 (2019) doi:10.1093/carcin/bgz079.
16. Zhang, Z. et al. TIPE1 induces apoptosis by negatively regulating Rac1 activation in hepatocellular carcinoma cells. Oncogene34, 2566–2574 (2015).
17. Qiu, S. et al. TIPE1 suppresses the invasion and migration of breast cancer cells and inhibits epithelial-to-mesenchymal transition primarily via the ERK signaling pathway. Acta Biochimica et Biophysica Sinica51, 1008–1015 (2019).
18. Chen, P., Zhou, J., Li, J., Zhang, Q. & Zuo, Q. TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage infiltration. Clin Transl Oncol21, 334–341 (2019).
19. Liu, W. et al. TIPE1 suppresses invasion and migration through down-regulating Wnt/β-catenin pathway in gastric cancer. J. Cell. Mol. Med. (2017) doi:10.1111/jcmm.13362.
20. Zhao, P. et al. TIPE1 promotes cervical cancer progression by repression of p53 acetylation and is associated with poor cervical cancer outcome. Carcinogenesis40, 592–599 (2019).
21. Jiang, J., Gao, L., Lan, Y., Wang, Y. & Zhao, P. TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner. Front. Oncol.10, 593615 (2021).
22. Li, D. et al. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clinical Immunology133, 422–427 (2009).
23. Ma, Y. et al. The Expression and Significance of TIPE2 in Peripheral Blood Mononuclear Cells from Asthmatic Children. Scand J Immunol78, 523–528 (2013).
24. Gus-Brautbar, Y. et al. The Anti-inflammatory TIPE2 Is an Inhibitor of the Oncogenic Ras. Molecular Cell45, 610–618 (2012).
25. Liu, Q.-Q. et al. TIPE2 Inhibits Lung Cancer Growth Attributing to Promotion of Apoptosis by Regulating Some Apoptotic Molecules Expression. PLoS ONE10, e0126176 (2015).
26. Yin, H. et al. Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial–mesenchymal transition. Cancer Gene Ther24, 180–188 (2017).
27. Fayngerts, S. A. et al. TIPE3 Is the Transfer Protein of Lipid Second Messengers that Promote Cancer. Cancer Cell26, 465–478 (2014).
28. Cui, J. et al. Identical Expression Profiling of Human and Murine TIPE3 Protein Reveals Links to Its Functions. J Histochem Cytochem.63, 206–216 (2015).
29. Ru, B. et al. TISIDB: an integrated repository portal for tumor–immune system interactions. Bioinformatics35, 4200–4202 (2019).
30. Vasaikar, S. V., Straub, P., Wang, J. & Zhang, B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Research46, D956–D963 (2018).
31. Ceccarelli, M. et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell164, 550–563 (2016).
32. Kirby, A. J. & Finnerty, G. T. New strategies for managing adult gliomas. J Neurol (2020) doi:10.1007/s00415-020-09884-3.
33. Kumar, D., Whiteside, T. L. & Kasid, U. Identification of a Novel Tumor Necrosis Factor-α-inducible Gene, SCC-S2, Containing the Consensus Sequence of a Death Effector Domain of Fas-associated Death Domain-like Interleukin- 1β-converting Enzyme-inhibitory Protein. J. Biol. Chem.275, 2973–2978 (2000).
34. Mall, R. et al. RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes. Nucleic Acids Research46, e39–e39 (2018).
35. Sun, L. et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell9, 287–300 (2006).
36. Han, S. et al. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma. Br J Cancer110, 2560–2568 (2014).
37. Domingues, P. et al. Tumor infiltrating immune cells in gliomas and meningiomas. Brain, Behavior, and Immunity53, 1–15 (2016).
38. Niture, S. et al. TNFAIP8 promotes prostate cancer cell survival by inducing autophagy. Oncotarget9, 26884–26899 (2018).
39. Bergamaschi, D. et al. Simultaneous polychromatic flow cytometric detection of multiple forms of regulated cell death. Apoptosis24, 453–464 (2019).